PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of westjmedLink to Publisher's site
 
West J Med. 1998 August; 169(2): 98–104.
PMCID: PMC1305178

Insulinoma--experience from 1950 to 1995.

Abstract

Insulinomas are rare tumors that originate from the islet cells of the pancreas. The purpose of this study was to analyze our experience in patients with insulinoma and present our approach to these patients. Medical records of 67 patients treated at the University of California, San Francisco (UCSF) Medical Center, 56 surgically and 11 medically, from 1954 to 1995 were retrospectively reviewed. Presenting symptoms, physical findings, laboratory data, pre and intraoperative localization studies, operative management, operative success, and post-operative complications were analyzed. Among the entire cohort, there were 11 patients with Multiple Endocrine Neoplasia type I (MEN 1) and 7 patients with multiple tumors. 46 out of 48 patients (96%) having first operations for benign tumors and 5 out of 8 patients (63%) having reoperations for benign tumors were successful, as were 6 out of 12 patients (50%) having operations for islet cell carcinoma. Overall, preoperative localization studies were positive in only 46% of patients and therefore failed to improve our surgical outcome. Careful palpation with intraoperative ultrasonography gave the best localization results. Enucleation of solitary tumors is curative in sporadic cases and gives the lowest complication rate. In patients with MEN 1, subtotal pancreatectomy with enucleation of tumours from the pancreatic head and uncinate process is recommended over simple enucleation because of frequent multiple tumors.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.6M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • HOWARD JM, MOSS NH, RHOADS JE. Hyperinsulinism and islet cell tumors of the pancreas; with 398 recorded tumors. Int Abstr Surg. 1950 May;90(5):417–455. [PubMed]
  • Whipple AO, Frantz VK. ADENOMA OF ISLET CELLS WITH HYPERINSULINISM: A REVIEW. Ann Surg. 1935 Jun;101(6):1299–1335. [PubMed]
  • Perry RR, Vinik AI. Clinical review 72: diagnosis and management of functioning islet cell tumors. J Clin Endocrinol Metab. 1995 Aug;80(8):2273–2278. [PubMed]
  • Delcore R, Friesen SR. Gastrointestinal neuroendocrine tumors. J Am Coll Surg. 1994 Feb;178(2):187–211. [PubMed]
  • Edis AJ, McIlrath DC, Van Heerden JA, Fulton RE, Sheedy PF, Service FJ, Dale AJ. Insulinoma--current diagnosis and surgical management. Curr Probl Surg. 1976 Oct;13(10):1–45. [PubMed]
  • Shatney CH, Grage TB. Diagnostic and surgical aspects of insulinoma. A review of twenty-seven cases. Am J Surg. 1974 Feb;127(2):174–184. [PubMed]
  • Filipi CJ, Higgins GA. Diagnosis and management of insulinoma. Am J Surg. 1973 Feb;125(2):231–239. [PubMed]
  • Laroche GP, Erris DO, Priestley JT, Scholz DA, Dockerty MB. Hyperinsulinism. Surgical results and management of occult functioning islet cell tumor: review of 154 cases. Arch Surg. 1968 May;96(5):763–772. [PubMed]
  • Grant CS, van Heerden J, Charboneau JW, James EM, Reading CC. Insulinoma. The value of intraoperative ultrasonography. Arch Surg. 1988 Jul;123(7):843–848. [PubMed]
  • Daggett PR, Goodburn EA, Kurtz AB, Le Quesne LP, Morris DV, Nabarro JD, Raphael MJ. Is preoperative localisation of insulinomas necessary? Lancet. 1981 Feb 28;1(8218):483–486. [PubMed]
  • Norton JA, Shawker TH, Doppman JL, Miller DL, Fraker DL, Cromack DT, Gorden P, Jensen RT. Localization and surgical treatment of occult insulinomas. Ann Surg. 1990 Nov;212(5):615–620. [PubMed]
  • Owens LV, Huth JF, Cance WG. Insulinoma: pitfalls in preoperative localization. Eur J Surg Oncol. 1995 Jun;21(3):326–328. [PubMed]
  • Demeure MJ, Klonoff DC, Karam JH, Duh QY, Clark OH. Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach. Surgery. 1991 Dec;110(6):998–1005. [PubMed]
  • van Heerden JA, Grant CS, Czako PF, Service FJ, Charboneau JW. Occult functioning insulinomas: which localizing studies are indicated? Surgery. 1992 Dec;112(6):1010–1015. [PubMed]
  • O'Riordain DS, O'Brien T, van Heerden JA, Service FJ, Grant CS. Surgical management of insulinoma associated with multiple endocrine neoplasia type I. World J Surg. 1994 Jul-Aug;18(4):488–494. [PubMed]
  • Rasbach DA, van Heerden JA, Telander RL, Grant CS, Carney JA. Surgical management of hyperinsulinism in the multiple endocrine neoplasia, type 1 syndrome. Arch Surg. 1985 May;120(5):584–589. [PubMed]
  • Angelini L, Bezzi M, Tucci G, Lirici MM, Candiani F, Rubaltelli L, Tremolada C, Tamburrano G, Fegiz G. The ultrasonic detection of insulinomas during surgical exploration of the pancreas. World J Surg. 1987 Oct;11(5):642–647. [PubMed]
  • Gorman B, Charboneau JW, James EM, Reading CC, Galiber AK, Grant CS, van Heerden JA, Telander RL, Service FJ. Benign pancreatic insulinoma: preoperative and intraoperative sonographic localization. AJR Am J Roentgenol. 1986 Nov;147(5):929–934. [PubMed]
  • Lo CY, Lam KY, Kung AW, Lam KS, Tung PH, Fan ST. Pancreatic insulinomas. A 15-year experience. Arch Surg. 1997 Aug;132(8):926–930. [PubMed]
  • Thompson GB, Service FJ, van Heerden JA, Carney JA, Charboneau JW, O'Brien PC, Grant CS. Reoperative insulinomas, 1927 to 1992: an institutional experience. Surgery. 1993 Dec;114(6):1196–1206. [PubMed]

Articles from The Western Journal of Medicine are provided here courtesy of BMJ Group